Impact of minimal residual disease prior to allogeneic stem cell transplantation in children with ALL.

被引：0
|
作者：
Bader, P
Hancock, J
Kreyenberg, H
Goulden, NG
Niethammer, D
Handgretinger, R
Oakhill, A
Steward, CG
Beck, JF
Klingebiel, T
机构：
[1] Univ Tubingen, Childrens Hosp, Tubingen, Germany
[2] Royal Hosp Sick Children, Bristol BS2 8BJ, Avon, England
[3] Univ Greifswald, Childrens Hosp, Greifswald, Germany
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1782
引用
收藏
页码：414A / 414A
页数：1
相关论文
共 50 条
  • [1] UTILITY OF MINIMAL RESIDUAL DISEASE LEVELS AT TIME OF ALLOGENEIC STEM CELL TRANSPLANTATION IN CHILDREN WITH ALL
    Buenasmananas, D.
    Molina, J. R.
    Serrano, J.
    Serrano-Lopez, J.
    Garcia-Torres, E.
    Rodriguez-Villa, A.
    Tabares, S.
    Rojas, R.
    Martin, C.
    Martinez, F.
    Gomez, P.
    Sanchez-Garcia, J.
    [J]. BONE MARROW TRANSPLANTATION, 2014, 49 : S500 - S500
  • [2] Prognostic value of minimal residual disease quantificaion prior to allogeneic stem-cell transplantation in relapsed childhood all. Results of the ALL-REZ BFM Study Group
    von Stackelberg, Arend
    Kreyenberg, Hermann
    Eckert, Cornelia
    Borkhardt, Arndt
    Peters, Christina
    Klingebiel, Thomas
    Henze, Guenter
    Bader, Peter
    [J]. PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 436 - 436
  • [3] Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL
    Bader, P
    Hancock, J
    Kreyenberg, H
    Goulden, NJ
    Niethammer, D
    Oakhill, A
    Steward, CG
    Handgretinger, R
    Beck, JF
    Klingebiel, T
    [J]. LEUKEMIA, 2002, 16 (09) : 1668 - 1672
  • [4] Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL
    P Bader
    J Hancock
    H Kreyenberg
    NJ Goulden
    D Niethammer
    A Oakhill
    CG Steward
    R Handgretinger
    JF Beck
    T Klingebiel
    [J]. Leukemia, 2002, 16 : 1668 - 1672
  • [5] Minimal residual disease status prior to allogeneic Stem Cell Transplantation (allo-SCT) in children with ALL has a profound impact on post-transplant outcome
    Bader, P
    Hancock, J
    Kreyenberg, H
    Goulden, NJ
    Niethammer, D
    Handgretinger, R
    Oakhill, A
    Steward, CG
    Beck, JF
    Klingebiel, T
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 : S54 - S54
  • [6] B-cell reconstitution after allogeneic stem cell transplantation impairs minimal residual disease monitoring in children with ALL
    Fronkova, E.
    Muzikova, K.
    Mejstrikova, E.
    Kovac, M.
    Formankova, R.
    Hrusak, O.
    Stary, J.
    Sedlacek, P.
    Trka, J.
    [J]. BONE MARROW TRANSPLANTATION, 2008, 41 : S333 - S333
  • [7] Minimal Residual Disease following Allogeneic Hematopoietic Stem Cell Transplantation
    Kroeger, Nicolaus
    Miyamura, Koichi
    Bishop, Michael R.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (01) : S94 - S100
  • [8] Influence of transplantation regimen on prognostic significance of high-level minimal residual disease before allogeneic stem cell transplantation in children with ALL
    Schneider, M
    Hettinger, K
    Matthes-Martin, S
    Konrad, M
    Peters, C
    Gadner, H
    Panzer-Grümayer, ER
    [J]. BONE MARROW TRANSPLANTATION, 2001, 28 (11) : 1087 - 1089
  • [9] Influence of transplantation regimen on prognostic significance of high-level minimal residual disease before allogeneic stem cell transplantation in children with ALL
    M Schneider
    K Hettinger
    S Matthes-Martin
    M Konrad
    C Peters
    H Gadner
    ER Panzer-Grümayer
    [J]. Bone Marrow Transplantation, 2001, 28 : 1087 - 1089
  • [10] BLINATUMOMAB REDUCES MINIMAL RESIDUAL DISEASE PRIOR TO ALLOGENEIC STEM CELL TRANSPLANT FOR CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
    Keating, Amy K.
    Gossai, Nathan
    Phillips, Christine L.
    Maloney, Kelly
    Campbell, Kristen
    Doan, Andrew
    Bhojwani, Deepa
    Burke, Michael J.
    Verneris, Michael R.
    [J]. PEDIATRIC BLOOD & CANCER, 2019, 66
12345